4-(2-Chloroethyl)phenyl methyl ether → 2-[(N-(2-(4-Methoxy-phenyl)-ethyl)-piperidin-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride
반응식
[NH:1]1[CH2:6][CH2:5][CH2:4][CH:3]([CH2:7][N:8]2[CH2:17][CH2:16][C:15]3[C:10](=[CH:11][C:12]4[O:20][CH2:19][O:18][C:13]=4[CH:14]=3)[C:9]2=[O:21])[CH2:2]1.[Cl:22][CH2:23][CH2:24][C:25]1[CH:30]=[CH:29][C:28]([O:31][CH3:32])=[CH:27][CH:26]=1>>[ClH:22].[CH3:32][O:31][C:28]1[CH:29]=[CH:30][C:25]([CH2:24][CH2:23][N:1]2[CH2:6][CH2:5][CH2:4][CH:3]([CH2:7][N:8]3[CH2:17][CH2:16][C:15]4[C:10](=[CH:11][C:12]5[O:20][CH2:19][O:18][C:13]=5[CH:14]=4)[C:9]3=[O:21])[CH2:2]2)=[CH:26][CH:27]=1참가 물질
3
실험 절차
Prepared from 2-[(piperidin-3-yl)-methyl]-6,7-methylenedioxy- 1-oxo-1,2,3,4-tetrahydro-isoquinoline and 1-chloro-2-(4-methoxy-phenyl)-ethane analogously to Example 1.
출처 및 근거
- ORD 기록
- ord-80d65bd01fc84c4ea3ed68a11b94d84e
- 출처 데이터셋
- uspto-grants-1992_12